Cargando…
Current Concepts in the Treatment of Giant Cell Tumors of Bone
SIMPLE SUMMARY: According to the 2020 World Health Organization classification, a giant cell tumor of bone is an intermediate malignant bone tumor. Denosumab treatment before curettage should be avoided due to the increased risk of local recurrence. Administration of denosumab before en bloc resecti...
Autores principales: | Tsukamoto, Shinji, Mavrogenis, Andreas F., Kido, Akira, Errani, Costantino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344974/ https://www.ncbi.nlm.nih.gov/pubmed/34359548 http://dx.doi.org/10.3390/cancers13153647 |
Ejemplares similares
-
Risk factors of fracture following curettage for bone giant cell tumors of the extremities
por: Tsukamoto, Shinji, et al.
Publicado: (2022) -
Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review
por: Morii, Rokuro, et al.
Publicado: (2021) -
Current Concepts in the Resection of Bone Tumors Using a Patient-Specific Three-Dimensional Printed Cutting Guide
por: Aiba, Hisaki, et al.
Publicado: (2023) -
Outcome of Reoperation for Local Recurrence Following En Bloc Resection for Bone Giant Cell Tumor of the Extremity
por: Tsukamoto, Shinji, et al.
Publicado: (2022) -
Late Local Recurrence of Bone Giant Cell Tumors Associated with an Increased Risk for Malignant Transformation
por: Tsukamoto, Shinji, et al.
Publicado: (2021)